Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Open accessThe DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations to PKD1 or PKD2, triggering progressive cystogenesis and typically leading to end-stage renal disease in midlife. The phenotypic spectrum, however, ranges from in utero onset to adequate renal function at old age. Recent patient data suggest that the disease is dosage dependent, where incompletely penetrant alleles influence disease severity. Here, we have developed a knockin mouse model matching a likely disease variant, PKD1 p.R3277C (RC), and have proved that its functionally hypomorphic nature modifies the ADPKD phenotype. While Pkd1+/null mice are normal, Pkd1RC/null mice have rapidly progressive disease, and Pkd1RC/RC animals develop gradual cystogenesis. These models effectively mimic the pathophysiological features of in utero-onset and typical ADPKD, respectively, correlating the level of functional Pkd1 product with disease severity, highlighting the dosage dependence of cystogenesis. Additionally, molecular analyses identified p.R3277C as a temperature-sensitive folding/trafficking mutant, and length defects in collecting duct primary cilia, the organelle central to PKD pathogenesis, were clearly detected for the first time to our knowledge in PKD1. Altogether, this study highlights the role that in trans variants at the disease locus can play in phenotypic modification of dominant diseases and provides a truly orthologous PKD1 model, optimal for therapeutic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies revealed that mutations in Prksch or Sec63 greatly reduce the expression, stability and proper trafficking of polycystin-1 (PC1), leading to cyst formation in a dose-dependent manner [426,427].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [427]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and proteomic profiling of exosomes in human urine
Pisitkun, T., Shen, R.-F., & Knepper, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403453101 · Cited by 2,174 · cited 2×
“21, 22).”
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Nauli, S. M., Alenghat, F. J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A. E. H., Lu, W., Brown, E. M., Quinn, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1076 · Cited by 2,057 · cited 2×
“However, in PKD1, the majority of studies have not detected cilia length defects, but the data are not conclusive, as these studies were largely conducted by light microscopy using cultured cells (14, 15, 80, 81).”
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationPKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L., Veldhuisen, B., Saris, J. J., Reynolds, D. M., Cai, Y., Gabow, P. A., Pierides, A., et al. (1996) · Science · doi:10.1126/science.272.5266.1339 · Cited by 1,406 · cited 1×
“3) and PKD2 (4q21), mutated in approximately 85% and 15% of cases, respectively (3–5).”
Hildebrandt, F., Benzing, T., & Katsanis, N. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1010172 · Cited by 1,331
A Highly Efficient Recombineering-Based Method for Generating Conditional Knockout Mutations
Liu, P., Jenkins, N. A., & Copeland, N. G. (2003) · Genome Research · doi:10.1101/gr.749203 · Cited by 1,013 · cited 1×
“A β -lactamase expression cassette flanked with a 3 ′ Sal I site was recom-bineered into IVS30, using the DY380 E. coli strain (63).”
Yoder, B. K., Hou, X., & Guay-Woodford, L. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000029587.47950.25 · Cited by 935
Hughes, J., Ward, C. J., Peral, B., Aspinwall, R., Clark, K., San Millán, J. L., Gamble, V., & Harris, P. C. (1995) · Nature Genetics · doi:10.1038/ng0695-151 · Cited by 910 · cited 1×
“82, 83).”
Self-citationDise, T. E. P. K. (1994) · Cell · doi:10.1016/0092-8674(94)90137-6 · Cited by 903
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
Hanaoka, K., Qian, F., Boletta, A., Bhunia, A. K., Piontek, K., Tsiokas, L., Sukhatme, V. P., Guggino, W. B., & Germino, G. G. (2000) · Nature · doi:10.1038/35050128 · Cited by 818 · cited 1×
“One possibility is that the PC complex acts as a mechanosensor, signaling via a Ca 2+ influx through PC-2, a TRP channel, after fluid flow detection by PC-1 (14, 16, 20).”
Cited by
Items 401–480 of 480
Use of 3D Robotic Ultrasound for In Vivo Analysis of Mouse Kidneys
Holmes, H. L., Stiller, A. A., Moore, C. J., Gregory, A., Roos, C. M., Miller, J. D., Gessner, R. C., Czernuszewicz, T. J., Kline, T. L., & Romero, M. F. (2021) · Journal of Visualized Experiments · doi:10.3791/62682-v
Wells, C. D., Lange, K., Thompson, A. F., Xu, W. M., Clendenon, S. G., Underwood, J. S., Harris, P. C., Herbert, B., Glazier, J. A., Wandinger‐Ness, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.01.482118
“The PKD1 model is characterized by a slowly progressive form of polycystic kidney disease (27).”
BackgroundSelf-citation(2013) · Kidney International · doi:10.1038/ki.2012.455
Banaras, F., Fazal, N., Nasir, M. F., Rana, M. Z., Banday, A. M., & Bashir, A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22169579
Rene policistico autosomico dominante: dalla patogenesi alla terapia
Piscopo, G. (2022) · Giornale di Clinica Nefrologica e Dialisi · doi:10.33393/gcnd.2022.2489
Current and Advance Treatment Approaches of Autosomal Dominant Polycystic Kidney Disease
Bisht, A. (2023) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v11i7.07
Pinto, V. C. D. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-01122023-173544
Liu, M. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/172816
Author response: Activation of Polycystin-1 Signaling by Binding of Stalk-derived Peptide Agonists
Pawnikar, S. P., Magenheimer, B. S., Joshi, K., Munoz, E. N., Haldane, A., Maser, R. L., & Miao, Y. (2024) · eLife · doi:10.7554/elife.95992.2.sa0
Activation of Polycystin-1 Signaling by Binding of Stalk-derived Peptide AgonistsPreprint
Pawnikar, S. P., Magenheimer, B. S., Joshi, K., Munoz, E. N., Haldane, A., Maser, R. L., & Miao, Y. (2024) · eLife · doi:10.7554/elife.95992.2
Activation of polycystin-1 signaling by binding of stalk-derived peptide agonists
Miao, Y., Magenheimer, B. S., Maser, R. L., Joshi, K., Pawnikar, S. P., Haldane, A., & Munoz, E. N. (2024) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/jsph-yt82
Vitulano, C., Forcina, G., Colosimo, S., Frattolillo, V., Villani, A. V., Marzuillo, P., del Giudice, E. M., & Sessa, A. D. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-024-00761-7
“A large body of evidence demonstrated that a reduced dosage of ADPKD genes promotes cyst growth in humans and mice [54–56].”
Shiiya, T., Watanabe, H., Aida, R., Otsuka, T., Kaseda, R., Yamamoto, S., Kaneko, Y., Goto, S., & Narita, I. (2025) · CEN Case Reports · doi:10.1007/s13730-025-00985-4
“Although the pathogenic mechanisms of PKD1 and PKD2 are not fully understood, ongoing research is aimed at elucidating their structures and the effects of mutations in these genes [3–6].”
mTOR promotes the formation and growth of tertiary lymphoid tissues in the kidney
Atwood, D. J., He, Z., Miyazaki, M., Hopp, K., Jani, A. H., Furgeson, S. B., Faubel, S. G., & Edelstein, C. L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1527817
“Pkd1 RC/RC mice Pkd1 RC/RC mice have a hypomorphic Pkd1 gene mutation orthologous to the PKD patient disease variant, PKD1 p. R3277C (24).”
Self-citationBarbosa, L. M. G. (2025) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2025.tde-06102025-160333
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714158
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714149
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714161
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714146
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714155
Additional file 1 of Novel GANAB variants associated with polycystic liver disease
van de Laarschot, L. F. M., te Morsche, R. H. M., Hoischen, A., Venselaar, H., Roelofs, H. M. J., Cnossen, W. R., Banales, J. M., Roepman, R., & Drenth, J. P. H. (2020) · Figshare · doi:10.6084/m9.figshare.13142393
Additional file 3 of Novel GANAB variants associated with polycystic liver disease
van de Laarschot, L. F. M., te Morsche, R. H. M., Hoischen, A., Venselaar, H., Roelofs, H. M. J., Cnossen, W. R., Banales, J. M., Roepman, R., & Drenth, J. P. H. (2020) · Figshare · doi:10.6084/m9.figshare.13142399
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714167
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714143
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714152
Nguyen, P. T. A. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-46076
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714164
Molecular diagnosis in inherited polycystic kidney disease
Mallawaarachchi, A. C. (2019) · UNSWorks (UNSW Sydney) · doi:10.26190/unsworks/21307
Wöstmann, F. (2023) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Polycystin-1 Protects Against DNA Damage and Atrial Fibrillation
Hendrickson, T. (2023) · OakTrust (Texas A&M University Libraries)
Phenotype analysis of a ciliopathy cohort with disease causing variants and renal involvement
Brislinger, L.-M. M. E., Höfele, J., & München, T. U. (2024)
Andries, A. (2021) · Lirias
Baatz, S. (2024) · Qucosa (Saxon State and University Library Dresden)
Elucidating the genetic architecture of cystic kidney disease using whole genome sequencing
Sadeghi‐Alavijeh, O. (2023) · UCL Discovery (University College London)
Mapping the genetic landscape of polycystic liver disease
van de Laarschot, L. F. M. (2022) · Radboud Repository (Radboud University)
Mullenger, J. (2025) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Metabolic Insights into Cyst Fluid Composition and the Role of Taurine in Polycystic Kidney Disease
Garimella, V. (2025) · Digital Commons - University of South Florida (University of South Florida)
Sägmüller, J. G. (2025) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Zhao, J., Yu, K., & Huang, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1741795
Reversible cystogenesis in juvenile primate ADPKD models: evidence from PKD1 heterozygous monkeys
Matsumoto, S., Morimura, T., KOBAYASHI, K. P., Tsuji, K., Nakaya, M., Tsukiyama, T., Kawamoto, I., Nakagawa, T., Morishige, E., 福田, 康., et al. (2026) · Human Molecular Genetics · doi:10.1093/hmg/ddag011
Apelin inhibits cyst growth and improves kidney function in mice with polycystic kidney diseasePreprint
Nyimanu, D., Chakraborty, A., Parnell, S. C., Wallace, D. P., & Yu, A. S. L. (2026) · bioRxiv · doi:10.64898/2026.03.26.714294
“Pkd1 RC/RC mice, kindly provided by Peter Harris (Mayo Clinic), and Pkd2 -/+ mice, provided by Stefan Somlo (Yale) 28, 29 were maintained by the PKD Rodent Models and Drug-Testing Core at the University of Kansas Medical Center.”
疾患特異的ヒトiPS細胞を用いた新規ADPKD病態モデルの作製
Shimizu, T. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.15068/0002005627
Rôles de la protéine anks 6 et de la métalloprotéase matricielle 9 dans la polykystose rénale
Bakey, Z. (2014) · theses.fr (ABES) · doi:10.70675/626f391fz5b4cz403bzadd1z417ec15bc7c6
Gall, É. C.-L. (2015) · theses.fr (ABES) · doi:10.70675/4dc17972za0f7z477fza1abzfe9fd1ed0235
Development of a biomimetic multitube system in the case of the ADPKD
Myram, S. (2020) · theses.fr (ABES) · doi:10.70675/c98f29bbz7d68z445az955dz1e062d759a8f
Mazloum, M. (2023) · theses.fr (ABES) · doi:10.70675/942268dezbd49z43b5z9e83z91370cce2711
Generation of ADPKD in vitro models for genotype-phenotype correlation and drug discovery
Scarlat, A. (2024) · theses.fr (ABES) · doi:10.70675/f7abe2d0zf681z4f39zab08z8f4ecec624ce
The Kinetics and Mechanism of Niche Filling in Healthy and Cystic Mice
Yashchenko, A., Miller, S. J., Cordova, A. M., Yashchenko, M. E., Khan, S., Maryam, B., Darby, I. G., Park, Y., Nusrat, F., Ahmed, U. K. B., et al. (2026) · Kidney360 · doi:10.34067/kid.0000001217
Fouillen, A., Couvineau, P., Mouillac, B., & Bous, J. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112835
Giblin, J., Lambaren, K., LaMastro, V., Suzuki, I., Huang, Y., Simon, R., Zarate‐Diaz, J., Osouli, A., Pham, J., Hallows, K. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.02.728835
“Accordingly, future studies will prioritize evaluating therapeutic efficacy in alternative ADPKD models that more closely reflect the human genetic landscape, including Pkd2 WS25/- and Pkd1 RC/RC strains 41–43 .”
Timing Matters: Decoding the microRNA Landscape of Polycystic Kidney Disease
Nyimanu, D., & Yu, A. S. L. (2026) · Kidney360 · doi:10.34067/kid.0000001264
Single-nucleus Transcriptomics Reveals Precystic Dysfunction in Polycystic Kidney DiseasePreprint
Marquez, J., Tymchyshyna, O., Gombart, S. K., Houghtaling, S. R., Huang, G., Mandel, A. M., Nguyen, E. D., & Beier, D. R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.23.730438
“Kidneys of Pkd1 R3277C/R3277C (RC) mice remain largely devoid of cysts over the first month of life but consistently develop cysts over the course of the next few months ( 12 ).”
PKD2 structural destabilization drives primary cilia degeneration and ADPKD pathogenicityPreprint
Outeda, P., Wang, Q., Vien, T. N., Palomero, O. E., Kimura, L. F., Summers, P., Watnick, T. J., Qian, F., Cao, E., & DeCaen, P. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.24.734313
Myofibroblast- specific autophagy drives cyst growth in autosomal dominant polycystic kidney disease
Jamadar, A., Remadevi, V., Varghese, M. M., Yang, H., Thakkar, V. P., Chandrasekar, I., Ding, W., Haase, V. H., Wallace, D. P., & Rao, R. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03054-0
“The Pkd1 RC/RC mouse (RC/RC) carrying a p.R3277C mutation is an orthologous model of ADPKD [27].”
Combination siRNA delivery as a therapeutic strategy for ADPKDPreprint
Giblin, J., Suzuki, I., Huang, Y., Lambaren, K., LaMastro, V., Simon, R., Zarate‐Diaz, J., Osouli, A., Pham, J., Bae, S. L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.20.739663
“Thus, validation in hypomorphic models such as Pkd1 RC/RC will be important 52 .”
Human Organoids as Drug Development Tools for Polycystic Kidney Disease
Fu, H., & Freedman, B. (2026) · The Nephron journals/Nephron journals · doi:10.1159/000553552
Li, Z., Guo, Z., Cho, S., Bhardwaj, R., Dong, K., Fedeles, S. V., & Besse, W. (2026) · Journal of Clinical Investigation · doi:10.1172/jci203177
“Kidney disease severity correlates with the degree of PC1 dosage loss (30, 31, 34, 35).”
Ursu, R., Buchholz, B., & Skoczynski, K. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00222.2026
Schirmer, J., Ruck, L., Dahlmann, A., Linz, P. R., Tkotz, K., Höhn, J. M., Ursu, R., Kraus, A., Haerteis, S., Nuebel, B., et al. (2026) · medRxiv · doi:10.64898/2026.07.30.26359242
Dysregulated ferritin and iron homeostasis in autosomal dominant polycystic kidney disease
Sommer, N., Placide, S., Weatherly, E., Wang, W., Begum, R., Dunfield, M., Singh, S., Ward, C. J., Tran, P. V., Bolisetty, S., et al. (2026) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00106.2026
Self-citationModeling Complex Developmental Disease: The Case of Polycystic Kidney Disease
DeLoriea, J., Casey, C., Shearer, L., Chen, V., Bryant, A., & Gamberi, C. (2026) · Journal of Developmental Biology · doi:10.3390/jdb14030036
Targeting Runx1 Slows Cyst Growth in Autosomal Dominant Polycystic Kidney Disease
Zhang, Y., Liu, C., Liu, J., Li, L. X., Torres, V., Li, X., & Zhou, J. X. (2026) · The FASEB Journal · doi:10.1096/fj.202600741r
“Pkd1 p.R3277C knock-in mice ( Pkd1 RC/RC ) were originally generated by Dr. Peter Harris at Mayo Clinic [26].”
Self-citationCao, Y., Sun, X., Huang, Y., Chen, C., Ji, B., Chen, R., Li, Y., Liang, Y., Aghevli, A., Yang, N., et al. (2026) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000001269
Self-citationChakraborty, A., Varghese, M. M., Wallace, D. P., Ward, C. J., & Yu, A. S. L. (2026) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90084.2026
Self-citationHu, E., Gardener, M. J., Wang, X., Luo, G., Kotzer, C., Jiang, L., MALLICK, E., Srinivasan, A., Ouro-Gnao, L., Firczuk, H., et al. (2026) · Kidney International · doi:10.1016/j.kint.2026.08.020
Self-citationCastro, A. M. (2023) · Rovira & Virgili repository
Activation of Disease-Associated Polycystin-1 Mutants by Binding of Stalk-derived Agonist PeptidesPreprint
Joshi, K., Magenheimer, B. S., Haldane, A., Zhang, Y., Maser, R. L., & Miao, Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.10.758211
Goll, R. (2026) · FreiDok plus (Universitätsbibliothek Freiburg) · doi:10.6094/unifr/288776
Primary cilium-mediated mechanisms of cyst formation in polycystic kidney disease
Qian, F., & Mukhopadhyay, S. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01139-0
Autosomal Dominant Polycystic Kidney Disease Diagnosis and the Cutting Edge of Genomic Medicine
Muto, S. (2026) · Juntendō Igaku/Juntendo igaku · doi:10.14789/ejmj.jmj26-0038-p
Metadata
- Authors
- Hopp, K., Ward, C. J., Hommerding, C. J., Nasr, S. H., Tuan, H.-F., Gainullin, V. G., Rossetti, S., Torres, V. E., & Harris, P. C.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Harris, Peter C.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-15
- Volume
- 122
- Issue
- 11
- Pages
- 4257-4273
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3484456
- OpenAlex
- W2085346322
- Cited by
- 442
- References
- 112
- Citations by year
- 2026: 34 · 2025: 34 · 2024: 45 · 2023: 43 · 2022: 44 · 2021: 44 · 2020: 38 · 2019: 23 · 2018: 19 · 2017: 20 · 2016: 21 · 2015: 31 · 2014: 26 · 2013: 18
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic (DK090728)
- American Heart Association
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-058816, DK090728, R01DK044863, P30DK090728, R01DK058816)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- autosomal dominant polycystic kidney disease, polycystin-1, PKD1, hypomorphic allele, dosage dependence, disease severity, cyst formation, knockin mouse model, primary cilia, collecting duct, temperature-sensitive mutants, phenotypic variability
- MeSH terms
- Animals, Disease Models, Animal, Severity of Illness Index, Polycystic Kidney, Autosomal Dominant, Protein Folding, Amino Acid Substitution, Mutation, Missense, Animals, Genetically Modified, TRPP Cation Channels, Mice, Gene Knock-In Techniques, Genetic Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.